The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2024
Filed:
Jan. 13, 2021
Applicant:
Starton Therapeutics, Inc., Paramus, NJ (US);
Inventors:
James Oliver, Raleigh, NC (US);
Fotios Plakogiannis, Whitestone, NY (US);
Tamanna Lather, Jersey City, NJ (US);
Marina Borovinskaya, East Brunswick, NJ (US);
Nisarg Modi, Bellerose, NY (US);
Rod L. Hartwig, Sloatsburg, NJ (US);
Assignee:
Starton Therapeutics, Inc., Paramus, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/70 (2006.01); A61K 9/00 (2006.01); A61K 31/5513 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/20 (2006.01); A61K 47/38 (2006.01); A61P 1/08 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7053 (2013.01); A61K 9/0053 (2013.01); A61K 9/7061 (2013.01); A61K 9/7069 (2013.01); A61K 31/5513 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/20 (2013.01); A61K 47/38 (2013.01); A61P 1/08 (2018.01);
Abstract
Compositions, devices, and methods for transdermal administration of olanzapine and uses thereof, e.g., to treat nausea and vomiting.
Oliver, James. (2024). Treatment of vomiting and nausea with minimum dose of olanzapine (U.S. Patent No. 11975112). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11975112
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile